RSV fusion inhibitors (WuXi AppTec/Roche)

N/A

Report date: 2025/03/19 11:40:36
NME

Base Information

Drug NameRSV fusion inhibitors (WuXi AppTec/Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRespiratory syncytial virus F protein inhibitors
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuxi Apptec Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding LtdWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A